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a b s t r a c t
We used the LEW1.WR1 rat model of Kilham Rat Virus (KRV)-induced type 1 diabetes (T1D) to test the
hypothesis that disease mechanisms are linked with beta cell infection and intra-islet immune activation
prior to insulitis. KRV induces genes involved in type I and type II interferon pathways in islet cell lines
in vitro and in islets from day-5-infected animals in vivo via mechanisms that do not involve insulitis,
beta cell apoptosis, or impaired insulin expression. Immunohistochemistry studies indicated that KRV
protein is expressed in beta cells 5 days following infection. KRV induces the phosphorylation of Janus
Kinase 1/2 (JAK1/2) and signal transducer and activator of transcription 1 (STAT-1) in islet cells via a
mechanism that could involve TLR9 and NF-κB pathways. These data demonstrate for the ﬁrst time that
KRV-induced islet destruction is associated with beta cell infection and intra-islet innate immune
upregulation early in the disease process.
& 2014 Elsevier Inc. All rights reserved.
Introduction
It is hypothesized that viruses play a key role in triggering type
1 diabetes (T1D) in genetically susceptible individuals (Fujinami
et al., 2006; Jun and Yoon, 2001, 2003; Laitinen et al., 2014), but
how they lead to T1D is not yet clear. Recent studies support the
hypothesis that the process of islet destruction involves beta cell
infection and intra-islet innate immune upregulation; however
the data supporting this hypothesis were obtained from in vitro
studies (Schulte et al., 2012; Sarkar et al., 2012), or pancreata from
humans with established islet autoimmunity (Dotta et al., 2007,
2010; Roep et al., 2010).
We used the LEW1.WR1 rat model of Kilham Rat Virus (KRV)-
induced T1D to identify in vivo disease mechanisms in the
preinsulitis stage. The LEW1.WR1 rat has normal T lymphocyte
levels and function (Mordes et al., 2005). Infection of this rat with
KRV leads to islet inﬁltration and destruction detectable beginning
at 2 weeks following virus inoculation (Zipris et al., 2003). KRV is a
single stranded DNA parvovirus (Jacoby et al., 1996), encoding
three overlapping structural proteins, VP1, VP2, and VP3, and two
overlapping nonstructural proteins, NS1 and NS2 (Jacoby et al.,
1996).
STAT pathways have recently been implicated in the mechan-
ism of T1D (Kim et al., 2007; Eizirik et al., 2009). They play a
central role in mediating the delivery of IFN-α⧸β and IFN-γ
signaling (for reviews, see Refs. Platanias (2005); Shuai and Liu
(2003)). The binding of IFN-α⧸β and IFN-γ to their receptors
results in the rapid auto-phosphorylation and activation of the
receptor-associated Janus activated kinases (JAKs) and tyrosine
kinase 2 (TYK2). Activation of the JAKs leads to tyrosine phos-
phorylation of STAT-1 and STAT-2 and to the formation of homo-
dimeric (STAT-1–STAT-1), heterodimeric (STAT-1–STAT-2), and
heterotrimeric (STAT-1–STAT-2–IFN-regulatory factor 9) com-
plexes. These complexes translocate to the nucleus and bind IFN-
stimulated response elements in DNA to initiate the transcription
of genes involved in host defense.
It is not yet clear whether and how pancreatic islets are linked
with early mechanisms of KRV-induced diabetes prior to insulitis.
Previous in situ hybridization studies suggested that KRV-induced
islet destruction does not involve beta cell infection (Brown et al.,
1993). In this study, we revisit this issue using newly developed
KRV-speciﬁc antibodies and further examine the hypothesis that
early disease mechanisms involve the upregulation of intra-islet
immune mechanisms. We demonstrate that inoculation of LEW1.
WR1 rats with KRV leads to the expression of virus transcripts and
protein in islet cells and to activation of the JAK–STAT signaling
Contents lists available at ScienceDirect
journal homepage: www.elsevier.com/locate/yviro
Virology
http://dx.doi.org/10.1016/j.virol.2014.07.041
0042-6822/& 2014 Elsevier Inc. All rights reserved.
n Correspondence to: Barbara Davis Center for Childhood Diabetes, University of
Colorado Denver, 1775 Aurora Ct., Mail Stop B-140, Aurora, CO 80045, United states.
Tel.: þ1 303 724 0108; fax: þ1 303 724 6839.
E-mail address: danny.zipris@ucdenver.edu (D. Zipris).
1 Authors equally contributed to this work.
Virology 468-470 (2014) 19–27
pathway in beta cells on day 5 post-infection. We hypothesize that
the mechanism of virus-induced islet destruction involves beta
cell infection and innate immune upregulation early in the disease
process.
Results
KRV induces proinﬂammatory gene expression in islet cells
in vitro and in vivo
Recent in vitro studies suggested that human T1D involves the
induction of proinﬂammatory responses in pancreatic islets
(Sarkar et al., 2012; Schulte et al., 2012). We tested the hypothesis
that KRV-induced T1D in the LEW1.WR1 rat involves proinﬂam-
matory gene expression in islet cells. To do so, we employed two
experimental systems. First, we measured the level of transcripts
for proinﬂammatory genes in the INS-1 and RIN-14B islet cell lines
which produce insulin and somatostatin, respectively (Moore et
al., 2011), following incubation in the presence or absence of KRV.
We also analyzed proinﬂammatory gene expression in islets
isolated from naïve uninfected (n¼3 to 7) versus day-5-infected
rats (n¼5 to 7). Data presented in Fig. 1A indicate that KRV
induces the expression of transcripts for IRF-7, a transcription
factor involved in type I interferon signaling (Honda et al., 2005),
in both INS-1 and RIN-14B cell lines (po0.007 and po0.002,
respectively). KRV also induced the expression of transcripts for
CXCL-10 in RIN-14B (po0.002) but not in INS-1 cells. Consistent
with these observations, data presented in Fig. 1B further demon-
strate that there was a signiﬁcant increase in the level of
transcripts for IFN-γ (p¼0.04), CXCL-10 (p¼0.02), CXCL-11
(p¼0.004), IRF-7 (p¼0.001), IFN-α (p¼0.02), STAT-1 (p¼0.04),
and JAK-2 (p¼0.003) in islets 5 days following infection compared
to uninfected rats. Fig. 1C further indicates that islets from days 3,
5, and 8 post-infection are insulitis-free. Taken together, these data
imply that infection with KRV results in proinﬂammatory gene
activation in islets on day 5 post-infection via a mechanism that is
not associated with insulitis.
KRV infects islet cell lines in vitro and beta cells in vivo
Previous data implied that virus-induced T1D does not involve
beta cell infection (Brown et al., 1993); however, the observation
that KRV upregulates proinﬂammatory gene expression in islets
in vitro and in vivo prompted us to revisit the issue of KRV
infectivity in islet cells. To that end, we tested the ability of KRV to
infect islet cells in vitro and in vivo. To assess in vitro infectivity,
the INS-1 and RIN-14B cell lines were cultured in the presence or
absence of KRV and the expression of virus transcripts was
assessed with quantitative RT-PCR. The data presented in Fig. 2A
indicate that transcripts for KRV are detectable in both the INS-1
and RIN-14B cell lines following a 4 h incubation in the presence of
KRV but not medium only (n¼3–7, po0.001). Fig. 2A further
shows that transcripts for KRV VP2 are readily detectable in
pancreatic islets from 5-day-infected animals but not naive unin-
fected rats (p¼0.001 versus uninfected).
We next assessed the expression of KRV protein in islet cells
from day-5-infected (n¼5 to 7) versus naïve uninfected (n¼3 to 7)
rats. We used spleens from infected and uninfected rats as positive
and negative controls, respectively. A polyclonal rabbit antibody
against the C terminus of KRV VP1/VP2 was used to detect KRV
expression in beta cells. Because immunoﬂuorescence was not
Uninfected 3d KRV 5d KRV
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Fig. 1. Proinﬂammatory gene expression in islet cell lines and primary islets from virus-infected rats. RNA was extracted from INS-1 (upper panel) and RIN-14B (lower panel)
islet cell lines cultured in the presence or absence of KRV for 4 h (A) or pancreatic islets puriﬁed from 5-day-infected or naïve rats (B). The expression level of transcripts for
the indicated genes was assessed using quantitative RT-PCR. The results are expressed as the mRNA expression of the gene of interest relative to the expression of β-actin.
Statistical analyses were performed using the Mann–Whitney U test. Parafﬁn sections of pancreata from infected and uninfected animals at different time points following
infection as indicated in the ﬁgure were stained for insulitis with hematoxylin and eosin (C). The images shown are representative of at least three independent experiments.
A.K. Alkanani et al. / Virology 468-470 (2014) 19–2720
KRV
Insulin KRV
Uninfected
KRV
Insulin/KRV
Uninfected
KRV
 KRV
LEW1.WR1 Islets INS-1 RIN-14B
KRV/DAPI
Fig. 2. KRV expression in islet cells. RNAwas extracted from INS-1 and RIN-14B islet cell lines cultured in the presence or absence of KRV for 4 h or islets puriﬁed from 5-day-
infected and uninfected LEW1.WR1 rats as indicated (A). The expression level of KRV VP2 transcripts was assessed using quantitative RT-PCR. The results are expressed as the
mRNA expression of the gene of interest relative to the expression of β-actin. Statistical analyses were performed using the Mann–Whitney U test. Immunoﬂuorescence
staining was performed on spleens (B) and pancreata (C) from 5-day-infected and uninfected rats. Spleen sections were stained for KRV (green) and counterstained with
DAPI (blue). Sections of pancreata were stained for insulin (red) and KRV (brown). Images were obtained using a 20 objective. Colocalization is visualized on the merge
images. The data are representative of images obtained from three individual rats.
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able to detect viral expression in the pancreas, we used immuno-
ﬂuorescence combined with immunohistochemistry for virus
detection and co-localization analyses. The data presented in
Fig. 2B demonstrate reactivity against KRV in sections of spleens
from 5-day-infected but not uninfected rats. The data shown in
Fig. 2C further demonstrate that the reactivity against KRV could
be seen in insulin producing beta cells from 5-day-infected but not
control uninfected animals. Collectively, these ﬁndings suggest
that virus-induced T1D may involve direct infection of beta cells
with KRV 5 days after infection.
Uninfected 3d KRV
5d KRV 8d KRV
Fig. 3. Beta cell function. Pancreata and sera were removed from infected and uninfected animals on different time points following virus inoculation as indicated. Beta cell
apoptosis and insulin expression were evaluated in parafﬁn sections of pancreata using immunoﬂuorescence by staining for insulin (red) and TUNEL (green) (A). The level of
insulin in the serum was assessed by ELISA (B). The results shown are representative of at least three independent experiments.
Fig. 4. KRV induces pSTAT-1 expression in islet cells in vitro. Islet cell lines (A) or primary islets isolated from naïve rats (B) were cultured in the presence or absence of KRV,
TLR agonists or type I and type II interferons as indicated. The cells were lysed and the lysate was subjected to Western blotting for pSTAT-1 and total STAT-1 protein
detection. Densitometry performed on the bands shown in Panel B demonstrated a 1.4-fold increase in the level of pSTAT-1 in islets cultured in the presence of KRV
compared with the control. No differences were observed in the expression level of STAT-1. Panel C: RIN-14B cells were cultured with or without KRV in the presence or
absence of serial dilutions of the indicated TLR and NF-κB inhibitors. The cells were lysed and subjected to Western blotting for the expression of the pSTAT-1 and STAT-1. The
results are representative of at least three independent experiments. iCpG, inhibitory CpG; CQ, chloroquine; PDTC, pyrrolidine dithiocarbamate.
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Infection with KRV does not lead to impaired insulin expression in
islets or peripheral blood on day 5 post-infection
We next tested whether expression of KRV in pancreatic beta
cells involves beta cell apoptosis or abnormal insulin expression.
Immunohistochemistry data indicate that like control rats, beta
cells from days 3, 5 and 8 exhibit minimal apoptosis (Fig. 3A).
Furthermore, similar insulin expression was observed in beta cells
from day-5-infected versus the uninfected control (Fig. 3A). Con-
sistent with these observations, Fig. 3B demonstrates that the level
of insulin in the serum from day-5-infected rats was similar to that
of the control (n¼5/group). These data imply that infection of
islets with KRV does not result in altered insulin expression on day
5 following virus inoculation.
KRV induces pSTAT-1 pathway in rat islet cell lines and islets in vivo
Because we observed that infection with KRV induces tran-
scripts for IFN-α, IFN-γ, and STAT-1 in islet cells on day 5 post-
infection (Fig. 1B), and since STAT-1 plays a major role in mediat-
ing type I and type II interferon biological effects (Platanias, 2005)
and was earlier implicated in islet destruction (Rasschaert et al.,
2005), we tested the possibility that KRV activates the STAT-1 to
undergo phosphorylation in islet cells. To do so, we cultured islet
cell lines or primary islets from naïve rats in the presence or
absence of KRV and analyzed the expression of pSTAT-1 (n¼3). We
used puriﬁed TLR ligands and type I and type II interferons that
induce STAT signaling as a positive control. Fig. 4A shows that
consistent with the notion that KRV is a rat-speciﬁc virus, it
induced the expression of pSTAT-1 in the rat INS-1 and RIN-14B
islet cells lines, but not mouse MIN-6 cells. Moreover, unlike KRV,
ligands of TLR3, TLR7/8, and TLR9 were unable to induce pSTAT-1
expression in RIN-14B and INS-1 cell lines. Only Poly (I:C) induced
pSTAT-1 in mouse MIN-6 cells. Finally, all three islet cell lines
included in these studies responded to type I and type II inter-
ferons by upregulating pSTAT-1 expression.
Next, we assessed the level of pSTAT-1 and total STAT-1 in
primary islets cultured in the presence or absence of KRV. Fig. 4B
indicates that KRV induced a modest 1.4-fold increase in the level
of pSTAT-1 compared to the control (n¼3). No difference in the
level of the total STAT-1 protein was observed in islets incubated in
the presence of KRV versus the uninfected control.
Given that islets express TLR9 (Wen et al., 2004) and are
activated following TLR ligation (Rasschaert et al., 2005), we
examined the hypothesis that KRV induces STAT signaling in islet
cells via the TLR9 and NF-κB pathways. To this end, RIN-14B cells
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Fig. 5. KRV-induced pSTAT-1 in islets in vivo. Immunoﬂuorescence images of islets from 5-day-infected and uninfected LEW1.WR1 rats. Sections were stained with
antibodies against pSTAT-1, STAT-1, or the isotype control (red) and insulin (green) and counterstained with DAPI (blue) as indicated. Images were obtained using a 40
objective. Colocalization is visualized on the merge images. The data are representative of images obtained from three individual rats.
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were cultured in the presence or absence of KRV and the
respective inhibitors of TLR9 and NF-κB, iCpG and PDTC (n¼3).
These pathways have previously been implicated by us in the
development of T1D in the BioBreeding Diabetes Resistant (BBDR)
rat (Zipris et al., 2007). We also used chloroquine, a blocker of
endosomal acidiﬁcation, to determine whether acidiﬁcation of
endosomes is required for the induction of activated STAT-1.
Intracellular TLRs such as TLR3, 7, 8, and 9 are expressed in
endosomal compartments, thus allowing interactions with TLR
ligands such as viral DNA and RNA occurring in a pH-dependent
manner (de Bouteiller et al., 2005). Fig. 4C indicates that both iCpG
and PDTC suppressed the KRV-induced expression of pSTAT-1 in a
dose-dependent fashion. The data further indicate that CQ mark-
edly inhibited the virus-induced STAT-1 activation. Similar obser-
vations were made in INS-1 cells (data not shown).
Together, the data imply that KRV-induced STAT-1 activation in
islet cells may be dependent on TLR9 and NF-κB pathways and on
endosomal acidiﬁcation.
KRV induces pSTAT-1 expression in beta cells in vivo
The observation that KRV induces pSTAT-1 in islets in vitro led
us to hypothesize that infection with KRV results in STAT-1
activation in beta cells in vivo. To test this possibility, rats were
left untreated or were infected with KRV (n¼3 per group).
Pancreata were removed on day 5 post-infection and immuno-
ﬂuorescence was used for pSTAT-1, STAT-1 and insulin detection.
The data presented in Fig. 5 suggest that the expression level of
pSTAT-1 in islets from uninfected rats is minimal. In contrast, islets
from day-5-infected animals had higher expression levels of
pSTAT-1 that was localized in insulin producing cells and was
expressed in both the cytoplasm and nucleus. Almost no staining
was observed in sections incubated in the presence of the isotype
control. These ﬁndings suggest that infection with KRV induces
STAT-1 activation in beta cells on day 5 post-infection.
KRV induces JAK1/2 signaling in beta cells
Because the induction of STAT-1 is dependent on JAK1/2
activation (Platanias, 2005), we examined the hypothesis that
infection with KRV leads to JAK1/2 phosphorylation in beta cells
(n¼3 per group). The data presented in Fig. 6 demonstrate an
increase in the level of pJAK-1/2 in insulin producing cells from 5-
day-infected versus uninfected controls. Moreover, the data sug-
gest increased expression of JAK1/2 in the exocrine tissue sur-
rounding the islets from infected versus uninfected rats. These
ﬁndings could imply that infection with KRV induces the JAK-1/2
pathway in islets early after infection.
Discussion
How virus infections trigger T1D is not yet clear. It is hypothe-
sized that viruses induce T1D via mechanisms associated with
beta cell infection and immune upregulation; however most of the
data supporting this concept come from in vitro studies performed
in beta cell cultures (reviewed in Ref. Eizirik et al. (2009)). In this
study, we elucidated early mechanisms involved in the develop-
ment of virus-induced T1D. We present for the ﬁrst time in vivo
evidence of a link between beta cell infection and virus-induced
intra-islet immune activation and the development of the disease.
Furthermore, we show that beta cell infection on day 5 post-
infection is not associated with insulitis, apoptosis, or abnormal
insulin expression in the pancreas or peripheral blood.
The hypothesis that infection with KRV leads to virus expres-
sion in beta cells early in the disease course is supported by three
lines of evidence. We found that KRV transcripts can be detected in
JAK-2 Insulin JAK-2/Insulin
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JAK-1/Insulin/DAPI  JAK-1 Insulin JAK-1/Insulin
JAK-2/Insulin/DAPI
Fig. 6. KRV-induced pJAK-1 and pJAK-2 in islet in vivo. Immunoﬂuorescence images of islets from 5-day-infected and uninfected LEW1.WR1 rats. Sections were stained with
antibodies against pJAK-1 and pJAK-2 (red) and insulin (green) and counterstained with DAPI (blue) as indicated. Images were obtained using a 40 objective. Colocalization
is visualized on the merge images. The data are representative of images obtained from three individual rats.
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islet cell lines cultured in the presence of the virus. Furthermore,
infection of rats with KRV results in the expression of KRV
transcripts and protein in islets or beta cells from 5-day-infected
rats. Our data implying that viral proteins are detectable in beta
cells are in contrast to previous data demonstrating that KRV is not
expressed in insulin producing cells on day 5 following infection
(Brown et al., 1993). This discrepancy is probably due the higher
detection sensitivity of the RT-PCR and immunohistochemistry
methodologies we have used compared to in situ hybridization
employed in the earlier study (Brown et al., 1993).
Our in vitro and in vivo ﬁndings suggesting that KRV activates
the JAK–STAT pathway in beta cells are reminiscent of our earlier
data that this virus induces a robust STAT-1 activation in lymphoid
cells in vitro and in vivo (Ref. Nair et al. (2008) and data not
shown). Furthermore, the fact that transcripts for type I and type II
interferons are expressed in islets from infected rats (this manu-
script) could provide a mechanistic explanation for the upregula-
tion of JAK–STAT upregulation. Engagement of the IFN-α and IFN-γ
receptors activates JAK-1 and TYK-2 and JAK-1 and JAK-2, respec-
tively (Leonard and O'Shea, 1998). This leads to the recruitment
and phosphorylation of STAT proteins, their dimerization and
nuclear translocation resulting in the synthesis of proinﬂamma-
tory cytokines and chemokines involved in anti-viral responses
(Platanias, 2005; Ivashkiv and Donlin, 2014). The data showing
that KRV infects beta cells and induces intra islet immune
mechanisms on day 5 post-virus inoculation may explain a
previous report that endoplasmic reticulum (ER) stress pathways
are upregulated in beta cells from KRV-infected BBDR rats on day 4
post-infection (Yang et al., 2013). Indeed, virus infection has
previously been linked with the upregulation of ER stress path-
ways (Saeed et al., 2011).
The data indicating that virus-induced T1D involves beta cell
infection and inﬂammation is consistent with the hypothesized role
of pancreatropic viruses such as enteroviruses in triggering T1D in
humans (Schulte et al., 2012). It was recently demonstrated that
Coxsackie B enterovirus (CVB) viral protein-1 is expressed in insulin-
producing beta cells from newly diagnosed patients with T1D
compared with control individuals (Richardson et al., 2009). Similar
to our data, previous studies indicated that infection of human beta
cells with CVB3 in vitro can trigger the expression of genes associated
with type I and type II interferon signaling (Schulte et al., 2012).
The presence of transcripts for CXCL-10 in KRV-infected islet
cells in vitro and in islets in vivo supports the hypothesis that
disease mechanisms could be linked with the upregulation of
CXCL-10 in the microenvironment of islets prior to insulitis. These
data are consistent with earlier reports that islets from patients
with T1D co-express enterovirus-capsid protein, interferon-γ,
CXCL10 and other chemokines (Roep et al., 2010; Tanaka et al.,
2009), and CXCL10 is the dominant chemokine expressed in vivo
in islets from humans and animal models (Sarkar et al., 2012).
CXCL-10 is a major chemoattractant for activated T-cells and
macrophages and can be produced and released by beta cells
following infection (Frigerio et al., 2002). It is conceivable that the
expression of CXCL-10 in islet cells from infected rats may be
involved in recruiting immune cells to the site of inﬂammation.
Although it was demonstrated that beta cells can express proin-
ﬂammatory cytokines and chemokines such as type I and type II
interferons and CXCL-10 (Schulte et al., 2012; Uno et al., 2010), our
studies do not identify the cell subsets expressing these immune
mediators. We were unable to detect cytokine and chemokine
proteins in islets from infected rats probably due to their low
expression level. We are therefore unable to exclude the possibility
that cells other than islets are involved in the KRV-induced
proinﬂammatory response. In addition to beta cells, islets contain
other types of endocrine cells as well as various types of immune
cells such as dendritic cells and macrophages.
Infection with KRV results in the induction of IRF-7, a major
transcription factor involved in the synthesis of type I IFNs (Honda
et al., 2005) in islet cell lines in vitro and in vivo (this manuscript).
Additionally, the amount of transcripts for IRF-7 signiﬁcantly
correlated with the levels of KRV on day 5 post-infection (data
not shown), implying a direct relationship between virus infection
and type I IFN induction. The ﬁnding that TLR9 and NF-κB
inhibitors block the STAT-1 activation in islet cell lines in vitro is
in accordance with our previous observation demonstrating that
the upregulation of innate immunity in spleen cells induced by
KRV is dependent on TLR9 and NF-κB pathways (Zipris et al.,
2007). Beta cells express TLR9 (Wen et al. (2004) and our
unpublished observations) and it can thus be assumed that the
KRV-induced proinﬂammatory signature in islet cells might be
mediated by TLR9. Based on these considerations, one can envision
a model in which TLR9 ligation by KRV in the periphery or islets
may lead to the expression of transcription factors involved in the
production and signaling of type I and type II interferons as well as
other proinﬂammatory cytokines and chemokines in islets and/or
immune cells recruited to the islets, culminating in inﬂammation
and islet destruction. The presence of type I and type II interferons
in the microenvironment of beta cells has been shown to be
detrimental for beta cells (Dogusan et al., 2008).
In conclusion, we present in vivo evidence linking islet infec-
tion and innate immune activation early in the disease process
with mechanisms of KRV-induced islet destruction in the LEW1.
WR1 rat model. Identifying immune pathways associated with the
early course of T1D may facilitate the development of new means
to prevent islet destruction.
Materials and methods
Animals, viruses and cell lines
Speciﬁc pathogen-free LEW1.WR1 rats were obtained from
BRM Inc. (Worcester, MA) and were bred and housed in a speciﬁc
pathogen-free facility and maintained in accordance with the
Guide for the Care and Use of Laboratory Animals (Institute of
Laboratory Animal Resources, National Research Council, National
Academy of Sciences, 1996) and the guidelines of the Institutional
Animal Care and Use Committee of the University of Colorado
Denver.
KRV and NRK cells were obtained from stocks maintained in
our laboratories (Guberski et al., 1991). KRV was propagated in
NRK cells, grown in Dulbecco's minimal essential medium
(DMEM) and quantiﬁed using plaque assays, as was previously
described (Zipris et al., 2003). The pancreatic cell lines INS-1, RIN-
14B, and MIN-6 were kindly provided by Dr. John Hutton (Barbara
Davis Center for Childhood Diabetes, University of Colorado
Denver).
KRV infection, tissue removal, and serum insulin measurements
Rats at 21 days of age were injected i.p. with 1107 PFU of KRV
as previously described (Guberski et al., 1991). The animals were
monitored for insulitis and T1D for 40 days following infection or
were sacriﬁced on day 5 post-infection. Pancreata or puriﬁed islets
were isolated from uninfected or KRV-treated rats at different time
points following virus inoculation. Spleens and sera were collected
from uninfected or day-5-infected animals. Serum insulin levels
were quantitated using an ELISA kit from Alpco Diagnostics
(Salem, NH).
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Histological analysis and ﬂuorescence microscopy of pancreata
and spleens
Pancreatic tissue was ﬁxed for 24 h in 10% neutral-buffered
formalin, embedded in parafﬁn, cut (5–6 μm), and mounted
on microscope slides. The tissue was stained with hematoxylin
and eosin.
For insulin and apoptosis detection, pancreata were embedded
in Tissue-Tek OCT (Miles, Elkhart. IN), snap frozen and stored at
80 1C until use. Cryostat sections (5 μm) were mounted on
slides. Sections were labeled with a monoclonal antibody against
mouse insulin (Clone K36AC10, Sigma-Aldrich) followed by Texas
Reds dye-conjugated AfﬁniPure donkey anti-mouse IgG (HþL)
(Jackson ImmunoResearch, West Grove, PA). For the detection of
apoptosis and nucleus staining, we used a Tunel staining kit
(Roche Applied Science, Indianapolis, IN) and 40,6-Diamidine-20-
phenylindole dihydrochloride (DAPI, from Sigma-Aldrich), respec-
tively. For a positive control, sections were incubated in the
presence of DNase I (Sigma-Aldrich) to induce DNA strand breaks,
prior to the labeling procedure. For a negative control, sections
were incubated with label solution only.
For staining KRV or JAK/STAT staining, pancreata or spleens
were removed from control uninfected or 5-day-infected rats.
Five-micrometer sections of formalin-ﬁxed, parafﬁn-embedded
tissues were mounted on slides, deparafﬁnized in xylene, and
then rehydrated with distilled H2O through graded alcohols.
Antigen retrieval was enhanced by microwaving the slides in
citrate buffer (pH 6). For KRV staining, pancreas and spleen
sections were incubated with rabbit polyclonal antibody against
the C-terminus portion of KRV VP1/VP2 (Bioss, Woburn, MA)
followed by incubation with donkey anti-rabbit IgG (H&L)-Alexa
ﬂuor 488 (Jackson ImmunoResearch, West Grove, PA). For detect-
ing KRV in the pancreas, sections were incubated with HRP-
conjugated goat anti-rabbit IgG (H&L) (Dako, Carpinteria, CA)
and bound HRP was localized with diaminobenzidine tetrachlor-
ide (Dako). For pJAK-1 (Tyr 1022), pJAK-2 (Tyr 1007/Tyr 1008),
STAT-1, and pSTAT-1 (Tyr 701) detection, we used rabbit polyclonal
antibodies from Santa Cruz Biotechnology (Santa Cruz, CA) fol-
lowed by Cy3-conjugated donkey anti-rabbit (Jackson ImmunoR-
esearch). Anti-human α-synuclein from Santa Cruz was used as an
isotype control. For the insulin staining in this part of the study we
used guinea pig anti-mouse/rat/human insulin (Abcam, Cam-
bridge, MA) followed by FITC-conjugated donkey anti-guinea pig
(Jackson ImmunoResearch). Sections from pancreata were also
stained with mouse against human insulin mAb followed by
incubation with donkey anti-mouse IgG (HþL) conjugated to
Cy3 (Jackson ImmunoResearch). DAPI (Sigma-Aldrich) was added
to the slides prior to mounting with cover slips.
Tissue sections were analyzed using an Olympus BX51-TRF
Microscope BX51 (Olympus, Center Valley, PA) equipped with a
Penguin Pro-150 ES Camera system (Pixera, Los Gatos, CA).
Islet isolation and TLR activation and blockade
Pancreatic islets were isolated from KRV-infected and control
uninfected BBDR rats by digestion with collagenase and puriﬁca-
tion by Histopaque (both from Sigma-Aldrich) as described pre-
viously (Nicolls et al., 2002). The islets were free of acinar tissue.
Activation of primary islets was performed by incubating 800
islets per 1 ml in the presence or absence of 2107 PFU/ml of KRV.
Islet cell lines were activated by incubating 4106 cells per ml in
the presence or absence of 2107 PFU/ml of KRV, or puriﬁed TLR
agonists with or without TLR inhibitors for 4 h as previously
described (Zipris et al., 2007). For TLR activation we used 50 mg/
ml of poly (I:C), 1 mg/ml for CpG DNA (Life Technologies), or
R848 (Axxora, San Diego, CA). TLR blockade was induced with
chloroquine and pyrrolidine dithiocarbamate (PDTC) from Sigma-
Aldrich and inhibitory CpG (iCpG) from Life Technologies. For
interferon-induced islet cell activation, we used rIFN-α and rIFN-β
from PBL (Piscataway, NJ) and rIFN-γ from PeproTech (Rocky
Hill, NJ).
RNA extraction, cDNA synthesis, and quantitative RT-PCR
RNA extraction, cDNA synthesis and quantitative RT-PCR were
performed as previously described (Wolter et al., 2009). The
primers used were synthesized by Integrated DNA Technologies
(Coralville, IA) and their sequences have been previously published
(Wolter et al., 2009).
Western blot analyses
Pancreatic islets, RIN-14B, INS-1, and MIN-6 islet cell lines were
lysed and subjected to Western blotting as previously described
(Zipris et al., 2005). The antibodies used were as follows: anti-pSTAT-
1 (clone ST1P-11A5 and mouse IgG2a) from Life Technologies
(Carlsbad, CA) and anti-STAT-1 (clone 42/Stat1 and mouse IgG2b)
purchased from BD Biosciences (San Jose, CA), and a rabbit polyclonal
anti-beta-actin purchased from Abcam (Cambridge, MA).
Statistical analysis
Comparisons between two experimental groups were per-
formed using the Mann–Whitney U test.
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